591 related articles for article (PubMed ID: 20667783)
21. Circulating tumour cells in breast cancer--review.
Vertakova KB; Sanislo L; Spanik S; Svec J; Ondrus D
Klin Onkol; 2010; 23(2):86-91. PubMed ID: 20465086
[TBL] [Abstract][Full Text] [Related]
22. Circulating and disseminated tumor cells in the management of breast cancer.
Ross JS; Slodkowska EA
Am J Clin Pathol; 2009 Aug; 132(2):237-45. PubMed ID: 19605818
[TBL] [Abstract][Full Text] [Related]
23. Disseminated and circulating tumor cells: Role in effective cancer management.
Lin H; Balic M; Zheng S; Datar R; Cote RJ
Crit Rev Oncol Hematol; 2011 Jan; 77(1):1-11. PubMed ID: 20570170
[TBL] [Abstract][Full Text] [Related]
24. Different prognostic value of circulating and disseminated tumor cells in primary breast cancer: Influence of bisphosphonate intake?
Kasimir-Bauer S; Reiter K; Aktas B; Bittner AK; Weber S; Keller T; Kimmig R; Hoffmann O
Sci Rep; 2016 May; 6():26355. PubMed ID: 27212060
[TBL] [Abstract][Full Text] [Related]
25. Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients.
Becker S; Solomayer E; Becker-Pergola G; Wallwiener D; Fehm T
Breast Cancer Res Treat; 2007 Dec; 106(2):239-43. PubMed ID: 17260094
[TBL] [Abstract][Full Text] [Related]
26. New technologies for the detection of circulating tumour cells.
Gerges N; Rak J; Jabado N
Br Med Bull; 2010; 94():49-64. PubMed ID: 20418405
[TBL] [Abstract][Full Text] [Related]
27. Circulating tumor cells and bone marrow micrometastasis.
Alix-Panabières C; Riethdorf S; Pantel K
Clin Cancer Res; 2008 Aug; 14(16):5013-21. PubMed ID: 18698019
[TBL] [Abstract][Full Text] [Related]
28. Disseminated tumour cells in bone marrow are the source of cancer relapse after therapy.
Sai B; Xiang J
J Cell Mol Med; 2018 Dec; 22(12):5776-5786. PubMed ID: 30255991
[TBL] [Abstract][Full Text] [Related]
29. Circulating tumor cells: evolving evidence and future challenges.
Dotan E; Cohen SJ; Alpaugh KR; Meropol NJ
Oncologist; 2009 Nov; 14(11):1070-82. PubMed ID: 19897536
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic applications of cell-free and circulating tumor cell-associated miRNAs in cancer patients.
Mostert B; Sieuwerts AM; Martens JW; Sleijfer S
Expert Rev Mol Diagn; 2011 Apr; 11(3):259-75. PubMed ID: 21463236
[TBL] [Abstract][Full Text] [Related]
31. A perivascular niche in the bone marrow hosts quiescent and proliferating tumorigenic colorectal cancer cells.
Möhrmann L; Zowada MK; Strakerjahn H; Siegl C; Kopp-Schneider A; Krunic D; Strunk D; Schneider M; Kriegsmann M; Kriegsmann K; Herbst F; Ball CR; Glimm H; Dieter SM
Int J Cancer; 2020 Jul; 147(2):519-531. PubMed ID: 32077087
[TBL] [Abstract][Full Text] [Related]
32. The clinical significance of circulating tumor cells in the peripheral blood.
Elshimali YI; Grody WW
Diagn Mol Pathol; 2006 Dec; 15(4):187-94. PubMed ID: 17122646
[TBL] [Abstract][Full Text] [Related]
33. Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy.
Giesing M; Suchy B; Driesel G; Molitor D
BJU Int; 2010 Apr; 105(7):1000-10. PubMed ID: 19818074
[TBL] [Abstract][Full Text] [Related]
34. Detection and clinical relevance of tumor cells in blood and bone marrow of patients with colorectal cancer.
Vlems FA; Wobbes T; Punt CJ; Van Muijen GN
Anticancer Res; 2003; 23(1B):523-30. PubMed ID: 12680140
[TBL] [Abstract][Full Text] [Related]
35. Circulating tumor cells.
Hayes DF; Smerage JB
Prog Mol Biol Transl Sci; 2010; 95():95-112. PubMed ID: 21075330
[TBL] [Abstract][Full Text] [Related]
36. Let me do more than count the ways: what circulating tumor cells can tell us about the biology of cancer.
Budd GT
Mol Pharm; 2009; 6(5):1307-10. PubMed ID: 19634916
[TBL] [Abstract][Full Text] [Related]
37. The direct molecular analysis of metastatic precursor cells in breast cancer: a chance for a better understanding of metastasis and for personalised medicine.
Klein CA
Eur J Cancer; 2008 Dec; 44(18):2721-5. PubMed ID: 19022661
[TBL] [Abstract][Full Text] [Related]
38. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer.
Rahbari NN; Aigner M; Thorlund K; Mollberg N; Motschall E; Jensen K; Diener MK; Büchler MW; Koch M; Weitz J
Gastroenterology; 2010 May; 138(5):1714-26. PubMed ID: 20100481
[TBL] [Abstract][Full Text] [Related]
39. Global gene expression profiling of circulating tumor cells.
Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
[TBL] [Abstract][Full Text] [Related]
40. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.
Pfitzenmaier J; Ellis WJ; Hawley S; Arfman EW; Klein JR; Lange PH; Vessella RL
Urol Oncol; 2007; 25(3):214-20. PubMed ID: 17483018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
